SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.55 CNY | +6.08% |
|
+6.08% | -6.46% |
| Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
| Apr. 23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company provides two categories of products: pharmaceutical preparation and bulk drugs. The Company is also engaged in the research and development, production and sales of cardiovascular medical devices. The Company distributes its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
30.55
CNY
Average target price
37
CNY
Spread / Average Target
+21.11%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.46% | 4.6B | |
| +17.97% | 42.77B | |
| +20.21% | 22.23B | |
| +13.12% | 14.44B | |
| +12.19% | 13.05B | |
| +35.45% | 11.59B | |
| -8.80% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +5.03% | 4.97B |
- Stock Market
- Equities
- 002294 Stock
- News Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Salubris Pharma Gets Nod to Hold Clinical Trials of Diabetes Drug Candidate
